ClinicalTrials.Veeva

Menu

Cross-Sectional Survey on the Use of Tobacco Products - Germany

P

Philip Morris

Status

Unknown

Conditions

Tobacco Use

Treatments

Other: Survey on Use of Tobacco Products in IQOS Users
Other: Survey on Use of Tobacco Products in the General Population

Study type

Observational

Funder types

Industry

Identifiers

NCT03527017
P1-PMX-03-GER

Details and patient eligibility

About

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.

Full description

The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Germany and in adult IQOS users registered in the IQOS user database of Philip Morris GmbH (Germany IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are:

Estimate the prevalence of current tobacco use status in the study population. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse). Explore the association between self-reported health status and use of tobacco products in the study population. Explore the association between patterns of use (including misuse) with motivation to use, perceived quality attributes of IQOS (e.g. risk and self-reported changes since switching to the product, in a number of relevant domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in Germany registered in the Germany IQOS User Database.

Enrollment

7,489 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (all participants, including IQOS users):

  • Legally permitted to buy tobacco products in Germany (≥18 years of age).
  • Currently residing in Germany.
  • Able to read, write and understand German.
  • Consent to participate in the survey

Inclusion Criteria (IQOS users only):

  • Has used more than 100 HEETS tobacco sticks in his or her lifetime.
  • Is currently using IQOS.
  • Has access to the internet.
  • Is not currently employed by Philip Morris International or any of its affiliates

Exclusion Criteria:

  • Not meeting the inclusion criteria

Trial design

7,489 participants in 2 patient groups

General Population
Description:
Adults living in Germany.
Treatment:
Other: Survey on Use of Tobacco Products in the General Population
IQOS Users
Description:
Adult current IQOS users (at the time of survey) living in Germany who are registered in the Germany IQOS User Database and agreed to be contacted for research purposes at the time of registration.
Treatment:
Other: Survey on Use of Tobacco Products in IQOS Users

Trial contacts and locations

1

Loading...

Central trial contact

Luis Prieto, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems